H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Go back to H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.17 -0.32 (2.21%)
Previous Close $14.49    52 Week High $34.49 
Open $14.49    52 Week Low $20.39 
Day High $14.71    P/E N/A 
Day Low $14.14    EPS $-3.18 
Volume 58,538